Search - tctmd.com

Presenter: Guido Parodi, Benedetta Bellandi, Vincenzo Comito, Renato Valenti, Nazario Carrabba, Rossella Marcucci, Angela Migliorini, Erica Ramazzotti, Rosanna Abbate, David Antoniucci

January 31, 2013

Presentation TCT 2013

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Presenter: Andreas Baumbach, Harold Dauerman, Bernardo Cortese, Martial Hamon, Jayne Prats, Efthymios Deliargyris, Roxana Mehran, Gregg Stone

January 31, 2013

Advertisement

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

Los GPI son Superiores al Tratamientos de Rescate tras una Embolización Endovascular con Espirales contra Aneurismas Cerebrales

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

La Alta Reactividad Plaquetaria se asocia a Más Episodios Adversos tras Intervenciones Endovasculares

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Strategies of Clopidogrel Load and Atorvastatin Reload to Prevent Ischemic Cerebral Events in Patients Undergoing Protected Carotid Stenting: Results from the Randomized ARMYDA-9 CAROTID Study

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

Switching from Clopidogrel to Prasugrel in Patients Undergoing Coronary Stent Implantation

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content